文献速递血栓与止血

肝素诱导的血小板减少症患者对血小板因子4与肝素复合物的细胞免疫应答

Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia.
PubMed 文献 · J Thromb Haemost · 2018-06-05

研究比较健康对照(n=30)、体外循环心脏术后患者(n=17)和确诊肝素诱导的血小板减少症(HIT)患者(n=41)的外周血单个核细胞对血小板因子4(PF4)及PF4-肝素复合物的增殖反应。结果显示各组均出现增殖且肝素增强增殖,体外循环和HIT患者增殖反应显著高于健康对照;增殖为抗原特异性、依赖血小板,仅CD14+细胞增殖;两组患者白细胞介素-10和转化生长因子-β1水平显著低于健康对照。

要点

  • 各组外周血单个核细胞在PF4存在时均增殖,加入肝素后增殖增强。
  • 体外循环和HIT患者的增殖反应显著高于健康对照。
  • 增殖为抗原特异性、依赖血小板,仅CD14+细胞被鉴定为增殖细胞。

核心结论

  • 研究进一步证明对PF4-肝素复合物的细胞免疫致敏在肝素暴露前即已发生,并提示免疫失调可促进HIT。

研究设计与样本

  • 研究将健康对照(n=30)、接受体外循环心脏手术的术后患者(n=17)和确诊HIT患者(n=41)的外周血单个核细胞与PF4及PF4-肝素复合物共培养,以[3H]胸腺嘧啶掺入和5-乙炔基-2'-脱氧尿苷检测评估细胞增殖。

主要发现

  • 所有研究组的外周血单个核细胞在PF4存在时均增殖,加入肝素后增殖增强。
  • 体外循环患者和HIT患者的增殖反应显著高于健康对照。
  • 外周血单个核细胞增殖为抗原特异性、依赖血小板,仅CD14+细胞被鉴定为增殖细胞。
  • 体外循环患者和HIT患者产生的白细胞介素-10和转化生长因子-β1水平均显著低于健康对照。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

UNLABELLED: Essentials The immunogenesis of Heparin-induced thrombocytopenia (HIT) is not well understood. Immunization to platelet factor 4 (PF4)-heparin occurs early in life, before any heparin exposure. PF4 and PF4-heparin complexes induce the proliferation of CD14+ cells. Reduced levels of regulatory cytokines contribute to immune dysregulation in HIT. SUMMARY: Background Heparin-induced thrombocytopenia (HIT) is an adverse reaction to heparin characterized by thrombocytopenia and thrombotic complications. HIT is caused by pathogenic antibodies that bind to complexes of platelet factor 4 (PF4) and heparin, leading to platelet activation and inducing a hypercoagulable state. Previous studies have shown immunity to PF4-heparin complexes occurs early in life, even before heparin exposure; however, the immunogenesis of HIT is not well characterized. Objectives To investigate cellular proliferation in response to PF4-heparin complexes in patients with HIT. Patients/Methods Peripheral blood mononuclear cells (PBMCs) from healthy controls (n = 30), postoperative cardiac surgery patients who had undergone cardiopulmonary bypass (CPB) (n = 17) and patients with confirmed HIT (n = 41) were cultured with PF4 and PF4-heparin complexes. Cellular proliferation was assessed by [3 H]thymidine uptake and 5-ethynyl-2'-deoxyuridine detection. Results and Conclusions PBMCs proliferated in the presence of PF4, and this was enhanced by the addition of heparin in all study groups. CPB and HIT patients showed significantly greater proliferative responses than healthy controls. PBMC proliferation was antigen-specific, depended on the presence of platelets, and only CD14+ cells were identified as proliferating cells. Culture supernatants were tested for the levels of regulatory cytokines, and both CPB and HIT patients produced significantly lower levels of interleukin-10 and transforming growth factor-β1 than healthy controls. These findings further demonstrate cellular immune sensitization to PF4-heparin complexes occurs before heparin exposure, and suggests immune dysregulation can contribute to HIT.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Nazy I, Clare R, Staibano P, et al. Cellular immune responses to platelet factor 4 and heparin complexes in patients with heparin-induced thrombocytopenia. J Thromb Haemost. 2018. PMID: 29723924. doi:10.1111/jth.14132

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。